Compound information
- Natural Products
- ZC3148058
- Molecular Formula
- C27H28ClFN6O
- Molecular Weight
- 506.199715416 g/mol
- Structure
-
- IUPAC Name
- N-[4-(3-chloro-4-fluoro-anilino)-7-[3-methyl-3-(4-methylpiperazin-1-yl)but-1-ynyl]quinazolin-6-yl]prop-2-enamide
- InChI
- InChI=1S/C27H28ClFN6O/c1-5-25(36)33-23-16-20-24(30-17-31-26(20)32-19-6-7-22(29)21(28)15-19)14-18(23)8-9-27(2,3)35-12-10-34(4)11-13-35/h5-7,14-17H,1,10-13H2,2-4H3,(H,33,36)(H,30,31,32)
- InChI Key
- ZAJXXUDARPGGOC-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1
- Source
- ZINC000022453472
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 36 | Ring Count | 4 |
Heteroatom Count | 9 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 73.39 Å2 | LogP | 4.975 |
LogS | -4.558 | LogD | 4.237 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.995 | Pgp substrate | 0.048 |
HIA | 0.96 | F20 % | 0.991 |
F30 % | 0.847 | Caco-2 | -5.284 |
MDCK | -4.996 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.044 | PPB | 94.643 |
VD | 2.741 | Fu | 1.557 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.898 | CYP1A2 substrate | 0.789 |
CYP2A6 substrate | 0.53 | CYP2B6 substrate | 0.695 |
CYP2C19 inhibitor | 0.308 | CYP2C19 substrate | 0.835 |
CYP2C8 substrate | 0.885 | CYP2C9 inhibitor | 0.123 |
CYP2C9 substrate | 0.997 | CYP2D6 inhibitor | 0.5 |
CYP2D6 substrate | 0.928 | CYP2E1 substrate | 0.577 |
CYP3A4 inhibitor | 0.424 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.056 | CL | 6.925 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.355 | Hepatotoxicity | 0.987 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.278 |
FDAMDD | 0.945 | Skin Sensitization | 0.213 |
Carcinogenicity | 0.565 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.99 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.389 | IGC50 | 4.417 |
LC50FM | -2.742 | LC50DM | 5.743 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.132 | NR-AR-LBD | 0.815 |
NR-AhR | 0.809 | NR-Aromatase | 0.288 |
NR-ER | 0.251 | NR-ER-LBD | 0.601 |
NR-PPAR-gamma | 0.872 | SR-ARE | 0.974 |
SR-ATAD5 | 0.623 | SR-HSE | 0.863 |
SR-MMP | 0.917 | SR-p53 | 0.898 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.